NTCOC
MACK

Northern Trust Company of Connecticut’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Northern Trust Company of Connecticut’s Portfolio MACK Stock Details MACK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		$135K Sell
3,214
-81
-2% -$2.35K ﹤0.01% 1841
2013
Q3 		$98K Buy
3,295
+377
+13% +$13.2K ﹤0.01% 1852
2013
Q2 		$155K Buy
+2,918
New +$128K ﹤0.01% 1749

Other funds holding MACK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Northern Trust Company of Connecticut's MACK Position: Q4 2013 in Review

Northern Trust Company of Connecticut reduced its Merrimack Pharmaceuticals, Inc. (MACK) stake by 2.5% in Q4 2013, selling an estimated $2.35K and leaving 3,214 shares worth $135K. The position accounts for ﹤0.01% of the portfolio, ranked #1841.

Northern Trust Company of Connecticut first reported a position in MACK in Q2 2013 and has held it in 3 quarters since. The position peaked at $155K in Q2 2013. 93 funds tracked by Wall St. Rank hold MACK as of Q4 2013.

  • Northern Trust Company of Connecticut held 3,214 shares of Merrimack Pharmaceuticals, Inc. worth $135K as of Q4 2013.
  • Northern Trust Company of Connecticut sold 81 Merrimack Pharmaceuticals, Inc. shares in Q4 2013, an estimated $2.35K.
  • Merrimack Pharmaceuticals, Inc. made up ﹤0.01% of Northern Trust Company of Connecticut's portfolio in Q4 2013, its #1841 holding.
  • Northern Trust Company of Connecticut first reported a position in Merrimack Pharmaceuticals, Inc. in Q2 2013 and has held it in 3 quarters since.
  • Northern Trust Company of Connecticut's Merrimack Pharmaceuticals, Inc. position peaked at $155K in Q2 2013.
  • 93 funds tracked by Wall St. Rank held Merrimack Pharmaceuticals, Inc. as of Q4 2013.

Based on Northern Trust Company of Connecticut's 13F filing for Q4 2013, filed 12 Feb 2014.